In the present study, we employed a recently developed proteomic approach, catTFRE, to screen for previously unidentified TFs/TCs targets of SEL in MM cells, aiming to provide valuable insights for enhancing the efficacy of XPO1-targeted therapies. The gene discussed is XPO1; the disease is Miyoshi myopathy.